Innovative Biomarkers of Cardiovascular Complications Associated With Second-generation Bruton Tyrosine Kinase Inhibitor Treatments: a Single-center Cohort Study

Clinical trial NCT07174141 · RECRUITING

Trial details

NCT number: NCT07174141
Sponsor: Centre Hospitalier Universitaire Dijon
Status: RECRUITING
Study type: OBSERVATIONAL

Treatment With Second-generation Bruton's Tyrosine Kinase Inhibitors (Acalabrutinib, Zanubrutinib)

Start date: 2025-11-28
Primary completion: 2028-11-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.